Skip to content

Scapulothoracic Joint Mobilization With or Without Acromioclavicular Joint Mobilization in Sub-acromial Pain Syndrome

Effects of Scapulothoracic Joint Mobilization With or Without Acromioclavicular Joint Mobilization in Patients With Sub-acromial Pain Syndrome

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07331597
Enrollment
36
Registered
2026-01-12
Start date
2025-01-10
Completion date
2025-11-20
Last updated
2026-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subacromial Pain Syndrome

Keywords

Pain, Scapulothoracic Joint Mobilization, Acromioclavicular Joint Mobilization

Brief summary

the study was conducted to find out the effects of scapulothoracic joint mobilization with or without acromioclavicular joint mobilization in patients with sub-acromial pain syndrome.

Detailed description

the study was conducted to determine the effects on the pain, range of motion of shoulder joint and the SPADI score in patients with sub-acromial pain syndrome post intervention including scapulothoracic upward rotation, posterior tilting and outward rotation glide with or without combination of acromioclavicular inferior glide.

Interventions

OTHERScapulothoracic joint mobilization

during 1st week of treatment, patients received Maitland grade-II mobilization for upward rotation, posterior tilting and external rotation glide, 5-10 oscillations per minute, 3 sets with 10 repetitions with 30 seconds rest interval. during 2nd, 3rd and 4rth week, patients received grade- II and III Maitland mobilization for upward rotation, posterior tilting and external rotation glide, 3 sessions a week for 4 weeks

OTHERAcromioclavicular joint mobilization

during 1st week : Maitland grade-II mobilization for AC joint inferior glide, 5-10 oscillations per minute, 3 sets with 10 repetitions with 30 seconds rest interval. during 2nd, 3rd and 4rth week : Maitland grade-II, III for AC joint inferior glide, 5-10 oscillations per minute, 3 sets with 10 repetitions with 30 seconds rest interval, 3 sessions a week for 4 weeks.

Moist hot pack for 10-15 minutes on shoulder region in supine lying position. TENS modulated mode for 10 minutes. Scapular stabilization exercises including: scapular protraction and retraction, shoulder extension, shoulder external rotation, standing snow angels, standing weight shift, ball stabilization exercise, serratus anterior punch. 3 sets with 10 repetitions, 3 sessions a week for 4 weeks.

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
25 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Age 25 - 40 years * Genders both male and female * Patients having unilateral non-traumatic shoulder pain * Patients having pain for ≥ 3 months * According to Dutch Orthopedic Association Clinical Practice Guidelines 2 out of following 3 tests should be positive i.e. Hawkin's kennedy test, Painful arc test, and Infraspinatus resistance test * Positive scapular assistance test * Positive AC joint scarf test

Exclusion criteria

* Patients having bilateral shoulder pain * Younger than 25 and older than 40 years * With positive drop arm test for supraspinatus tears * Degenerative joint disease of shoulder * Patients diagnosed with frozen shoulder * Having history of shoulder fracture and dislocation * Patients diagnosed with cervical radiculopathy (19) * Having history of shoulder or neck surgery (19) * Patients who had steroid injections in shoulder joint in the past 6 months * Patients having other neurological, orthopedic and systemic problems affecting the shoulder, neck and back

Design outcomes

Primary

MeasureTime frameDescription
Numeric Pain Rating scalefrom enrolment to the end of 4 weeks of treatmentthis scale is used to evaluate pain. it consists of 11 points from 0 to 10, where 0 represents no pain, 1-3 represents mild pain, 4-6 moderate pain and 7-10 represents severe pain.
Shoulder Pain and Disability Index SPADIfrom enrolment to the end of 4 weeks treatmentthis questionnaire consisting of 13 items is used to assess the severity of pain and difficulty while performing daily life activities. two subscales for pain and disability. uses a visual Analog scale or Numeric rating scale for each item, resulting in scores from 0-100 for each sub-scale, with higher scores indicating more pain or disability.

Secondary

MeasureTime frameDescription
goniometer for shoulder flexion ROMfrom enrolment to the end of 4 weeks treatmentchanges in shoulder flexion range of motion was measured at baseline and after 4 weeks of treatment sessions using goniometer
Goniometer for shoulder extension ROMfrom enrolment to the end of 4 weeks of treatmentchanges in the shoulder extension range of motion were measured at baseline and at the end of 4 weeks of treatment sessions using goniometer
Goniometer for shoulder abduction ROMfrom enrolment to the end of 4 weeks treatment sessionschanges in the shoulder abduction range of motion were measured at baseline and at the end of 4 weeks of treatment sessions by using goniometer
Goniometer for shoulder adduction ROMfrom enrolment to the end of 4 weeks of treatmentchanges in shoulder adduction range of motion were measured at baseline and at the end of 4 weeks treatment sessions by using goniometer
Goniometer for shoulder external rotation ROMfrom enrolment to the end of 4 weeks of treatmentchanges in shoulder external rotation range of motion were measured at baseline and at the end of 4 weeks of treatment sessions by using goniometer
goniometer for shoulder internal rotation ROMfrom enrolment to the end of 4 weeks treatmentchanges in the shoulder internal rotation range of motion were measured at baseline and at the end of 4 weeks of treatment sessions by using goniometer

Countries

Pakistan

Contacts

PRINCIPAL_INVESTIGATORSaba Rafiq, MS-OMPT

Riphah International University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026